These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

389 related articles for article (PubMed ID: 38469234)

  • 1. Ferroptosis and EMT resistance in cancer: a comprehensive review of the interplay.
    Zhang H; Chen N; Ding C; Zhang H; Liu D; Liu S
    Front Oncol; 2024; 14():1344290. PubMed ID: 38469234
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ferroptosis and EMT: key targets for combating cancer progression and therapy resistance.
    Ren Y; Mao X; Xu H; Dang Q; Weng S; Zhang Y; Chen S; Liu S; Ba Y; Zhou Z; Han X; Liu Z; Zhang G
    Cell Mol Life Sci; 2023 Aug; 80(9):263. PubMed ID: 37598126
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting Ferroptosis Pathway to Combat Therapy Resistance and Metastasis of Cancer.
    Liu X; Zhang Y; Wu X; Xu F; Ma H; Wu M; Xia Y
    Front Pharmacol; 2022; 13():909821. PubMed ID: 35847022
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epigenetic reprogramming of epithelial-mesenchymal transition promotes ferroptosis of head and neck cancer.
    Lee J; You JH; Kim MS; Roh JL
    Redox Biol; 2020 Oct; 37():101697. PubMed ID: 32896720
    [TBL] [Abstract][Full Text] [Related]  

  • 5. d-Borneol enhances cisplatin sensitivity via autophagy dependent EMT signaling and NCOA4-mediated ferritinophagy.
    Li J; Yuan J; Li Y; Wang J; Xie Q; Ma R; Wang J; Ren M; Lu D; Xu Z
    Phytomedicine; 2022 Nov; 106():154411. PubMed ID: 36030746
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advances in the relationship between ferroptosis and epithelial-mesenchymal transition in cancer.
    Mu W; Zhou Z; Shao L; Wang Q; Feng W; Tang Y; He Y; Wang Y
    Front Oncol; 2023; 13():1257985. PubMed ID: 38023171
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The clustering status of detached gastric cancer cells inhibits anoikis-induced ferroptosis to promote metastatic colonization.
    Sun J; Li J; Pantopoulos K; Liu Y; He Y; Kang W; Ye X
    Cancer Cell Int; 2024 Feb; 24(1):77. PubMed ID: 38369484
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Crosstalk between ferroptosis and the epithelial-mesenchymal transition: Implications for inflammation and cancer therapy.
    Ebrahimi N; Adelian S; Shakerian S; Afshinpour M; Chaleshtori SR; Rostami N; Rezaei-Tazangi F; Beiranvand S; Hamblin MR; Aref AR
    Cytokine Growth Factor Rev; 2022 Apr; 64():33-45. PubMed ID: 35219587
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exploring the relationship between anastasis and mitochondrial ROS-mediated ferroptosis in metastatic chemoresistant cancers: a call for investigation.
    Cao Y; Lu C; Beeraka NM; Efetov S; Enikeev M; Fu Y; Yang X; Basappa B; He M; Li Z
    Front Immunol; 2024; 15():1428920. PubMed ID: 39015566
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HDAC inhibition induces EMT and alterations in cellular iron homeostasis to augment ferroptosis sensitivity in SW13 cells.
    Oliveira T; Hermann E; Lin D; Chowanadisai W; Hull E; Montgomery M
    Redox Biol; 2021 Nov; 47():102149. PubMed ID: 34600336
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combinative treatment of β-elemene and cetuximab is sensitive to KRAS mutant colorectal cancer cells by inducing ferroptosis and inhibiting epithelial-mesenchymal transformation.
    Chen P; Li X; Zhang R; Liu S; Xiang Y; Zhang M; Chen X; Pan T; Yan L; Feng J; Duan T; Wang D; Chen B; Jin T; Wang W; Chen L; Huang X; Zhang W; Sun Y; Li G; Kong L; Chen X; Li Y; Yang Z; Zhang Q; Zhuo L; Sui X; Xie T
    Theranostics; 2020; 10(11):5107-5119. PubMed ID: 32308771
    [No Abstract]   [Full Text] [Related]  

  • 12. Targeting GPX4 in human cancer: Implications of ferroptosis induction for tackling cancer resilience.
    Lee J; Roh JL
    Cancer Lett; 2023 Apr; 559():216119. PubMed ID: 36893895
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Eriocitrin inhibits epithelial-mesenchymal transformation (EMT) in lung adenocarcinoma cells via triggering ferroptosis.
    Gao M; Lai K; Deng Y; Lu Z; Song C; Wang W; Xu C; Li N; Geng Q
    Aging (Albany NY); 2023 Oct; 15(19):10089-10104. PubMed ID: 37787987
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lipid Peroxidation, GSH Depletion, and
    Sun L; Dong H; Zhang W; Wang N; Ni N; Bai X; Liu N
    DNA Cell Biol; 2021 Feb; 40(2):172-183. PubMed ID: 33351681
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ferroptosis: a novel strategy to overcome chemoresistance in gynecological malignancies.
    Xu J; Zheng B; Wang W; Zhou S
    Front Cell Dev Biol; 2024; 12():1417750. PubMed ID: 39045454
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epithelial-mesenchymal plasticity: Implications for ferroptosis vulnerability and cancer therapy.
    Lee J; Roh JL
    Crit Rev Oncol Hematol; 2023 May; 185():103964. PubMed ID: 36931615
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunometabolism of ferroptosis in the tumor microenvironment.
    Lupica-Tondo GL; Arner EN; Mogilenko DA; Voss K
    Front Oncol; 2024; 14():1441338. PubMed ID: 39188677
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mitochondrial pyruvate carrier 1 regulates ferroptosis in drug-tolerant persister head and neck cancer cells via epithelial-mesenchymal transition.
    You JH; Lee J; Roh JL
    Cancer Lett; 2021 Jun; 507():40-54. PubMed ID: 33741422
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epithelial-to-mesenchymal transition is dispensable for metastasis but induces chemoresistance in pancreatic cancer.
    Zheng X; Carstens JL; Kim J; Scheible M; Kaye J; Sugimoto H; Wu CC; LeBleu VS; Kalluri R
    Nature; 2015 Nov; 527(7579):525-530. PubMed ID: 26560028
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Harnessing Ferroptosis to Overcome Drug Resistance in Colorectal Cancer: Promising Therapeutic Approaches.
    Cheng X; Zhao F; Ke B; Chen D; Liu F
    Cancers (Basel); 2023 Oct; 15(21):. PubMed ID: 37958383
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.